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We previously found hypertrophy of the gut in F508del homozygous mice.
Objectives: To characterize the neuroendocrine and innervation pattern in the
intestines of wt, homo- and heterozygous F508del CFTR mice.
Methods: Specimens from the gastrointestinal tract were studied by immuno-
cytochemistry (ICC) for VIP, galanin, NPY, CGRP, CART, VAchT as well as NOS
and in situ hybridization (ISH) for VIP and CART mRNA. Enzymes involved in
the formation and degradation of S-1-P and C-1-P were studied by isotope-assays.
The muscle layer of the small intestine was thickened 4 times with hypertrophy of
both the circular and longitudinal layer. In nerve ﬁbres in the circular muscle VIP
immunostaining was more intense in CF than in wt mice. The other neuropeptides/
markers appeared unchanged. Furthermore, the submucosal VIP neurons (lacking
CART) had up regulated VIP-mRNA while the myenteric ones (CART positive)
had not. Instead CART-mRNA was upregulated in the myenteric VIP-neurons. This
is different from the ﬁndings in a mechanical ileus model in which VIP is increased
in both layers. No other differences were seen in endocrine intestinal cells (gastrin,
CCK, GIP, GLP-1, serotonin, secretin and somatostatin).
Conclusion: Homozygous F508del mice have thicker enteric muscular layers com-
pared to controls. Their VIP-containing ﬁbres in circular muscle, and submucosal
VIP neurons are more frequent and intensively immunoreactive. The relevance to
MI and DIOS in CF need further studies on humans.
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Objectives: The hallmark feature of pancreatic disease in cystic ﬁbrosis (CF) is the
production of viscous, low-volume and acidic ﬂuid. Because pancreatic function
studies in humans are done by sampling the jejunal ﬂuid, it is not known whether
pancreatic or biliary secretions are equally affected in CF. With a pancreatic
histopathology similar to humans with CF and separate biliary and pancreatic
duct openings into the intestine, the pig model offers an opportunity to examine
pancreatic and biliary ﬂuids separately.
Methods: Four WT, 3 CFTR−/− , and 2 CFTRDF508/DF508 newborn pigs were
studied. Bile and pancreatic juice were collected from blind intestinal loops at
baseline and 30min after secretin. Bile was also sampled from the gallbladder.
Results: Compared to WT pigs, pancreatic juice volume and pH were low in CF
pigs (8.4±0.1 in WT vs. 5.7±0.1 in CF). Contrary to WT, pancreatic juice volume
and pH did not increase in CF pigs following secretin. Bile volume and pH were not
different between WT and CF pigs at baseline, but unlike WT pigs, ﬂuid volume
did not increase in CF pigs. Gallbladder bile pH was not different between WT
and CF pigs. Compared to WT, pancreatic juice protein concentration was 8 fold
higher in CF pigs; bile protein concentration was 2 fold higher.
Conclusion: Pancreatic ﬂuid was acidic, low in volume and high in protein in CF
pigs. Bile volume and pH were not signiﬁcantly different between WT and CF
pigs, but bile volume did not increase after secretin in CF pigs. The differences
between the pancreatic and biliary secretion may have important implications in
the pancreaticobiliary disease pathogenesis in CF.
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Objectives: Ursodeoxycholate (UDCA) is used as treatment for cystic ﬁbrosis liver
disease (CFLD). It is hypothesized that the therapeutic action of UDCA is either
mediated via choleretic activity or via effects on bile salt (BS) metabolism. However,
the effects of UDCA on biliary BS composition and the enterohepatic circulation
of bile salts in CF conditions are unclear.
Methods: Cftr−/− and control mice were either fed UDCA enriched chow (0.5%
wt/wt) for 3 weeks. We evaluated the effects on the biliary BS composition and
on the biosynthesis rate (SR) and pool size (PS) of cholate (CA), the mayor
hydrophobic BS.
Results: In non UDCA treated Cftr−/− mice the fractional biliary CA content was
signiﬁcantly higher compared to controls (61% vs. 46%, resp.; p< 0.01). However,
the biliary UDCA enrichment was ~50% lower in Cftr−/− mice compared to controls
(3% vs. 6%, resp.; p< 0.01). Both the SR (16±1 vs.10±2mmol·100g−1 BW−1·day,
resp.; p< 0.01) and PS (28±3 vs. 18±1mmol·100g−1·BW−1, resp.; p< 0.01) were
signiﬁcantly higher in Cftr−/− mice compared to controls. After UDCA the biliary
BS composition consisted for more than ~80% of UDCA in both Cftr−/−mice and
controls. Both in Cftr−/− mice and controls UDCA treatment drastically diminished
the SR (−85% and −81%, resp. each p< 0.01) and PS (−87% and −92%, resp. each
p< 0.01).
Conclusion: Cftr−/− mice have a more hydrophobic biliary BS composition
compared to controls. In Cftr−/− mice the SR and the PS of CA are increased
compared to controls, leading to a more cytotoxic BS proﬁle. UDCA reduces the
hydrophobic BS proﬁle of Cftr−/− mice. This favorable effect of UDCA on bile salt
metabolism could contribute to the assumed beneﬁcial effects of UDCA in CFLD.
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Focal biliary ﬁbrosis may occur early in cystic ﬁbrosis (CF). TGF-bs are cytokines
that regulate proliferation and differentiation of a wide spectrum of cells. TGF-bs
signal through transmembrane threonine-kinase receptors, activating intracellular
mediators, called SMADs, which modulate the transcription of target genes. The
aim of this study was to investigate the contribution of TGF-b cytokines to the
hepatic ﬁbrosis in CF.
Methods: LD was demonstrated in 12 CF patients, who had a mean age of
12.5 years and underwent percutaneous liver biopsy with the biopsy needle directed
to the site of the lesion with the aid of CT scan. Hepatic tissue mRNA levels of
TGF-b1, TGF-b2, TGF-b3, CTGF, ALK-5 and Smad-2, -3, -4, -7 were estimated
by quantitative real-time RT-PCR.
Results: Strong correlation between the expression of TGF-bs, ALK-5, Smads
and CTGF at the ﬁbrosing process was observed (TGF-b3/TGF-b1 p: 0.0114,
Smad-2/ALK-5 p: <0.0001, Smad-3/ALK-5 p: 0.0011, Smad-3/Smad-2 p: 0.0030,
Smad-7/Smad-4 p: 0.0102, Ctgf/Smad-7 p: 0.0006, ALK-5/TGF-b1 p: 0.0001,
ALK-5/TGF-b3 p: 0.0006, Smad-2/TGF-b1 p: 0.0001, Smad-2/TGF-b3 p: 0.0045,
Smad-3/TGF-b3 p: 0.0114, Smad-7/TGF-b1 p: 0.0002, Smad-7/TGF-b3 p: 0.0139,
Smad-7/ALK-5 p: 0.0001, Smad-7/Smad-2 p: 0.0001, Smad-7/Smad-3 p: 0.0026,
Ctgf/TGF-b1 p: 0.0034, Ctgf/TGF-b2 p: 0.0261, Ctgf/ALK-5 p: 0.0114,
Ctgf/Smad-2 p: 0.0005). Signiﬁcant correlation between ﬁbrosis and inﬂammation
grade was also demonstrated (p: 0.0072).
Conclusion: The pathway of TGF–SMADs contributes to the ﬁbrosing process
of CFLD. There is an increase of the degree of inﬂammation in association with
ﬁbrosis. Thus, the measurement of tissue cytokines may be helpful in the assessment
of the degree of the reactive ﬁbrosing process in CFLD.
